Table 1.
Patient no. | Gender | Level of serum ALT ( IU/L) | Level of serum HBsAg (ng/mL) | HBV-DNA (copies/mL) | Expression of HLA-A2 |
---|---|---|---|---|---|
1 |
male |
200 |
527 |
1 × 107 |
positive |
2 |
male |
120 |
513 |
1.5 × 107 |
positive |
3 |
male |
135 |
468 |
6.3 × 106 |
positive |
4 |
female |
122 |
491 |
6.1 × 106 |
positive |
5 |
male |
150 |
132 |
8.7 × 106 |
positive |
6 |
female |
132 |
401 |
1.3 × 105 |
positive |
7 |
female |
197 |
401 |
5.1 × 106 |
positive |
8 |
male |
200 |
441 |
1.1 × 105 |
positive |
9 |
male |
101 |
356 |
7.5 × 104 |
positive |
10 |
female |
157 |
437 |
3.3 × 106 |
positive |
11 |
male |
156 |
491 |
2.0 × 105 |
positive |
12 |
female |
189 |
411 |
7.0 × 105 |
positive |
13 |
female |
172 |
328 |
5.4 × 106 |
positive |
14 |
male |
194 |
396 |
1.9 × 106 |
positive |
15 | female | 200 | 567 | 1.1 × 107 | positive |
Abbreviations: ALT, alanine transaminase; HBsAg, hepatitis B surface antigen; HBV, hepatitis B virus; HLA, human leukocyte antigen.